Efficacy of Ablative Therapies for Barrett's Oesophagus

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Some people with severe reflux develop Barrett's oesophagus, which puts them at high risk of developing cancer. Patients with Barrett's can be treated with various endoscopic ablation techniques, but it is not yet know if these treatments prevent the development of cancer. The aims of this work are to use molecular methods to ascertain whether the tissue that regenerates after ablation is normal, and to compare different ablation techniques.

Funded Activity Details

Start Date: 01-01-2011

End Date: 01-01-2014

Funding Scheme: Project Grants

Funding Amount: $570,148.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Surgery

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

Barrett's oesophagus | endoscopic surgery | endoscopy | gastro-oesophageal reflux disease (GERD) | molecular markers